Posts Tagged ‘Toy Story 3 review’

TOY STORY 3: PIXAR BASTARDS ENGULF THE WORLD IN TEARS AND SNOT

Not that I was planning on seeing the movie before reading this delightfully cynical review of Toy Story 3, but now I’m not even more. – Ilene 

TOY STORY 3: PIXAR BASTARDS ENGULF THE WORLD IN TEARS AND SNOT

By Eileen Jones, The eXiled 

WK-AU304_FILM1_F_20100617131616

Seriously, it beats me how people managed to develop such an appetite for sloppy sentimentality. With each successive hit feature, Pixar tests the limit of that appetite, and finds that there is no limit. Audiences drink up vats of Pixar’s patented corn syrup in animated film form, smack their sticky lips, and beg for more. Please, Pixar, could you make the characters even rounder and smoother and cuter, like a vast array of babies’ butts? Could everyone find out that everyone loves everyone else, and then all rescue each other ten or twelve times, with lots and lots of preaching along the way? Our tears, could they be jerked harder, to the point of actual pain and bruising this time?

Sure, says Pixar, and the ticket-money washes in like the tide.

Since this deplorable trend has been manifest for some time—our enabling of Pixar’s worst tendencies, I mean—it’s no surprise when they follow twee Wall-E with the grossly lugubrious Up and then top it all off with a sickening wallow like Toy Story 3. So why would I subject myself to this torture? Two reasons: 1) Michael Keaton as the voice of Ken Doll. I always liked Keaton and remain fascinated by the way he’s sabotaged his own career and squandered his great comic gifts. Keaton as Ken Doll looked funny in the previews, which gave me the faint hope that Pixar might stress the comedy over the sniveling in Toy Story 3. Curses, foiled again.

4c98dbb51e19e7c5c4

[...]

The professional critics, of course, can’t gush enough about Toy Story 3, which has a supernaturally high rating of 98% on the Rotten Tomatoes site, a score that should be reserved for the second coming of Jesus Christ artfully caught on film by the world’s best cinematographer. These godforsaken critics especially loved the last fifteen minutes, which I’m now going to describe…

[...]

What’s so distressing about all this, as I keep pointing out, is the tremendous talent of the Pixar team getting wasted on nostalgic goop, forever presenting idealized 1950s suburban culture as the norm. Superficial contemporary trappings like iPods and day-care centers and the occasional non-white minor character shouldn’t…
continue reading


Tags: , , , , , ,




 
 
 

Zero Hedge

Why the Fed will change its exit strategy...again

Courtesy of ZeroHedge. View original post here.

Submitted by Eugen Bohm-Bawerk.

This blog entry was originally posted at Bawerk.net you may also follow us on Twitter

In a press release
dated September 17, 2014 the Federal Reserve updated their "policy normalization
principles"  that was laid out in 2011 when our
monetary masters first flirted with the idea of "green shoots"
turning into "escape velocity." As mission got closer to completion
eternal bliss for all subjects lucky enough to be ...



more from Tyler

Phil's Favorites

News You Can Use From Phil's Stock World

 

Financial Markets and Economy

Putting Economic Models in Their Place (Brad DeLong, Project Syndicate)

When policymakers turn to economists for guidance, they expect the advice they receive to be grounded in science, not academic factionalism or political presuppositions. After all, the policies they will be putting in place will have real implications for real people. Unfortunately, however, sound science is not always the driving force behind economic analysis and policy recommendations.

In a recent critique of what he calls the “mathiness” of modern economics, Paul M. Romer of...



more from Ilene

Chart School

STTG Market Recap May 29, 2015

Courtesy of Blain.

It was quite a volatile week and indexes closed it off on a sour note as the S&P 500 fell 0.63% and NASDAQ 0.55%.  For the month of May the S&P 500 gained 1.05% while the NASDAQ added 2.6%.   Greece was again the focus – perhaps next week some eyes will return to economic data as the first week of the month is chock full of reports.   Consumer sentiment showed a final read of 90.7 for May, the lowest since November and below April’s 95.9 print.  A gauge today showed Chicago-area manufacturing activity contracted this month to its lowest level since February, raising concerns that the rebound from a weak first quarter lacks vitality.

Tuesday’s selloff led to a bull flag failure and despite the immediate bounce back Wednesday, this failure has stayed intact.

...



more from Chart School

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Kimble Charting Solutions

S&P 500 – Is it repeating the 2000 & 2007 topping pattern?

Courtesy of Chris Kimble.

CLICK ON CHART TO ENLARGE

Could the S&P 500 be pulling a repeat of the 2000-2007 topping process?

The chart above reflects that the tops in 2000 & 2007 were 7 years and 7 months apart. Is it possible that another top is taking place 7 years and 7 months from the 2007 high? As the S&P is facing this potential time window repeating pattern, it is also staring the Fibonacci 161% Extension resistance level based upon the 2007 highs and 2009 lows, at the top of a rising wedge.

Is the S&P the only market facing a breakout test? The chart below takes a look at the white hot DAX index.

...



more from Kimble C.S.

Sabrient

Sector Detector: Stocks provide a tepid breakout as Fed greases the skids. So now what?

Courtesy of Sabrient Systems and Gradient Analytics

Early last week, stocks broke out, with the S&P 500 setting a new high with blue skies overhead. But then the market basically flat-lined for the rest of the week as bulls just couldn’t gather the fuel and conviction to take prices higher. In fact, the technical picture now has turned a bit defensive, at least for the short term, thus joining what has been a neutral-to-defensive tilt to our fundamentals-based Outlook rankings.

In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then offer up some actionable trading ideas, including a sector rotation strategy using ETFs and an enhanced version using top-ranked stocks from the t...



more from Sabrient

OpTrader

Swing trading portfolio - week of May 24th, 2015

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Pharmboy

Big Pharma's Business Model is Changing

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Understanding the new normal of a business model is key to the success of any company.  The managment of companies need to adapt to the changing demand, but first they must recognize what changes are taking place.  Big Pharma's business model is changing rapidly, and much like the airline industry, there will be but a handful of pharma companies left at the end of this path.

Most Big Pharma companies have traditionally done everything from research and development (R&D) through to commercialisation themselves. Research was proprietary, and diseases were cherry picked on the back of academic research that was done using NIH grants.  This was in the heyday of research, where multiple companies had drugs for the same target (Mevocor, Zocor, Crestor, Lipitor), and could reap the rewards on multiple scales.  However, in the c...



more from Pharmboy

Digital Currencies

Nasdaq's bitcoin plan will provide a real test of bitcoin hype

 

Nasdaq's bitcoin plan will provide a real test of bitcoin hype

By 

Excerpt:

Bitcoin, the virtual digital currency, has been called the future of banking, a dangerous fad, and almost everything in between, but we're finally about to get some solid data to help settle the debate.

On Monday, the Nasdaq (NDAQ) stock exchange said it would ...



more from Bitcoin

Market Shadows

Kimble Charts: US Dollar

Which way from here?

Chris Kimble likes the idea of shorting the US dollar if it bounces higher. Phil's likes the dollar better long here. These views are not inconsistent, actually, the dollar could bounce and drop again. We'll be watching. 

 

Phil writes:  If the Fed begins to tighten OR if Greece defaults OR if China begins to fall apart OR if Japan begins to unwind, then the Dollar could move 10% higher.  Without any of those things happening – you still have the Fed pursuing a relatively stronger currency policy than the rest of the G8.  So, if anything, I think the pressure should be up, not down.  

 

UNLESS that 95 line does ultimately fail (as opposed to this being bullish consolidation at the prior breakout point), then I'd prefer to sell the UUP Jan $25 puts for $0.85 and buy the Sept $24 call...



more from Paul

Mapping The Market

An update on oil proxies

Courtesy of Jean-Luc Saillard

Back in December, I wrote a post on my blog where I compared the performances of various ETFs related to the oil industry. I was looking for the best possible proxy to match the moves of oil prices if you didn't want to play with futures. At the time, I concluded that for medium term trades, USO and the leveraged ETFs UCO and SCO were the most promising. Longer term, broader ETFs like OIH and XLE might make better investment if oil prices do recover to more profitable prices since ETF linked to futures like USO, UCO and SCO do suffer from decay. It also seemed that DIG and DUG could be promising if OIH could recover as it should with the price of oil, but that they don't make a good proxy for the price of oil itself. 

Since...



more from M.T.M.

Promotions

Watch the Phil Davis Special on Money Talk on BNN TV!

Kim Parlee interviews Phil on Money Talk. Be sure to watch the replays if you missed the show live on Wednesday night (it was recorded on Monday). As usual, Phil provides an excellent program packed with macro analysis, important lessons and trading ideas. ~ Ilene

 

The replay is now available on BNN's website. For the three part series, click on the links below. 

Part 1 is here (discussing the macro outlook for the markets) Part 2 is here. (discussing our main trading strategies) Part 3 is here. (reviewing our pick of th...

more from Promotions

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743

Thank you for you time!




FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>